Found: 19
Select item for more details and to access through your institution.
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31015-x
- By:
- Publication type:
- Article
Eight‐year follow up of a case of persistent polyclonal B cell lymphocytosis: Immunophenotypic findings pre‐ and postsplenectomy.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 6, p. 687, doi. 10.1002/cyto.b.21976
- By:
- Publication type:
- Article
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 698, doi. 10.1002/hon.2792
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01428
- By:
- Publication type:
- Article
Digital Droplet PCR is a Specific and Sensitive Tool for Detecting IDH2 Mutations in Acute Myeloid LeuKemia Patients.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1738, doi. 10.3390/cancers12071738
- By:
- Publication type:
- Article
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00528
- By:
- Publication type:
- Article
The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00532
- By:
- Publication type:
- Article
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0807-0
- By:
- Publication type:
- Article
The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00413
- By:
- Publication type:
- Article
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia.
- Published in:
- Frontiers in Pharmacology, 2016, v. 7, p. 1, doi. 10.3389/fphar.2016.00363
- By:
- Publication type:
- Article
Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Boron nitride nanotube-functionalised myoblast/microfibre constructs: a nanotech-assisted tissue-engineered platform for muscle stimulation.
- Published in:
- Journal of Tissue Engineering & Regenerative Medicine, 2015, v. 9, n. 7, p. 847, doi. 10.1002/term.1878
- By:
- Publication type:
- Article
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance
- Published in:
- Hematological Oncology, 2014, v. 32, n. 3, p. 133, doi. 10.1002/hon.2095
- By:
- Publication type:
- Article
Safety and efficacy of <sup>90</sup> Yttrium- Ibritumomab- Tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 5, p. 710, doi. 10.1111/bjh.12695
- By:
- Publication type:
- Article
Simultaneous Presentation of Waldenström Macroglobulinemia and Multiple Myeloma: Multidisciplinary Diagnosis, Treatment and 30-Month Follow-up.
- Published in:
- Journal of Clinical & Experimental Hematopathology, 2013, v. 53, n. 1, p. 29, doi. 10.3960/jslrt.53.29
- By:
- Publication type:
- Article
Discordant lymphoma consisting of splenic mantle cell lymphoma and marginal zone lymphoma involving the bone marrow and peripheral blood: a case report.
- Published in:
- 2011
- By:
- Publication type:
- journal article
WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes.
- Published in:
- 2010
- By:
- Publication type:
- Letter